Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.75
- Piotroski Score 2.00
- Grade Neutral
- Symbol (RAIN)
- Company Rain Therapeutics Inc.
- Price $1.21
- Changes Percentage (-1.63%)
- Change -$0.02
- Day Low $1.21
- Day High $1.27
- Year High $11.32
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.07
- Trailing P/E Ratio -0.58454106280193
- Forward P/E Ratio -0.58454106280193
- P/E Growth -0.58454106280193
- Net Income $-75,724,000
Income Statement
Quarterly
Annual
Latest News of RAIN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ukraine gets major NASAMS air defense boost from NATO ally
Ukrainian President Zelensky announced Canada's support for Ukraine in the war with Russia, with the first NASAMS air defense system set to be delivered by the end of the year. The system, developed b...
By Newsweek | 13 hours ago -
Xi's Balancing Act on Ukraine Disrupted by Putin-Kim Alliance
China is facing pressure to control its diplomatic allies, Russia and North Korea, amid concerns over escalating tensions. This poses a challenge for President Xi Jinping's efforts to maintain stabili...
By Yahoo! Finance | 14 hours ago -
Maps track North Korean troops front lines of Russia-Ukraine war
North Korean troops joining Putin's war in Ukraine faced attacks in the Kursk region, per a Kyiv official. Their presence is aimed at pressuring the US, but experts doubt their effectiveness in impact...
By Newsweek | 15 hours ago
